UBS Oncology Impact Fund L.P.

SPV or co-invest vehiclemanaged by MPM Bioimpact· Cayman Islands
Vintage
2023
Reported gross assets
$570M
Form ADV, Apr 28, 2026
Active deploymentFundraising status unknownADV: Other Private FundSingle-purpose vehicle

A single-purpose vehicle, usually formed for one deal.

More
As of · the latest observation of this vehicle; each figure below carries its own filing date

6 additional placement agents

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. -21%
    reported GAV

    Reported gross assets fell from $721M to $570M between the Form ADV filings of 26 Jun 2024 and 28 Apr 2026.

    The fund's assets as the adviser swears them, never its size or dry powder.

    Derivedtwo Form ADV Schedule D filingsFor LPs, secondaries buyersReporting →
Drawing the relationship network…
Amounts, each with its basis
Vintage
2023basis: adv first reported
Target
unknownnot announced
First close
unknownnever inferred from a Form D
Final close
unknownonly from an announcement or an LP disclosure
Announced size
unknown
Form D offering
unknownwhat may be sold, not what was raised
Form D sold
unknown
First sale
unknown
Reported GAV
$570Mon the Form ADV filed Apr 28, 2026; the fund's assets, never its size or dry powder
Owners (ADV)
660
Reported on ADV
Mar 30, 2023 to Apr 28, 2026
Structure
master
Fundraising evidence
Unknown
no Form D or close on record (fr-1)
Lifecycle
Active deployment
vintage 2 to 4 years
age years: 3first sale: n/avintage year: 2023adv gav as of: Apr 28, 2026vintage basis: ADV first reportedform d sold: n/aform d offering: n/aform d latest filed at: n/a
The fund's own reporting through time
7 Form ADV filings
FiledTypeGross asset value OwnersMin. investmentAdviser-ownedAudit
Mar 30, 2023Other Private Fund$785M
660$5.0M0%yes
Oct 30, 2023Other Private Fund$785M
660$5.0M0%yes
Mar 28, 2024Other Private Fund$721M
660$5.0M0%yes
Jun 6, 2024Other Private Fund$721M
660$5.0M0%yes
Jun 6, 2024Other Private Fund$721M
660$5.0M0%yes
Jun 26, 2024Other Private Fund$721M
660$5.0M0%yes
Apr 28, 2026Other Private Fund$570M
660$5.0M0%
Principals and agents
0 principals on Form D, 0 placement agents
No Form D related person on record.
Service providers
9 named on Form ADV Schedule D and Form D
Limited partners and their reported performance
0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Known LPs and allocators
0 relationships, public pensions and the allocator graph, each counted once
No allocator names this vehicle in a public disclosure DFX holds: pension reports, foundation 990-PF returns or endowment disclosures.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
1 event
  1. Mar 30, 2023
    UBS Oncology Impact Fund L.P. first reported on Form ADV by MPM Asset Management LLC (Other Private Fund), GAV $785,026,985
    Fund first reported on Form ADV Fact Form ADV
Evidence
0 observations
Every observation on this vehicle

    Relationships across DFX

    on 1 other DFX graph
    Across the graphs

    UBS Oncology Impact Fund L.P. is the same institution as 1 record in RIA and Wealth.

    RIA and Wealth1

    The joined record opens with the product, beside every other relationship on this page.

    Checking your plan…

    Record history

    1 dated event on the change ledger, latest event first
    • Fund first reported on ADV
      2023-03-30source on record

    The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.